Haematology

Doç. Dr. Pınar Tığlıoğlu

Doctor and researcher Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi İstanbul
Lymphoma, Large B-Cell, Diffuse
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lymphoma, Large B-Cell, Diffuse 2 publications
    Source: OpenAlex / PubMed MeSHView publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionGöztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLymphoma, Large B-Cell, DiffuseExtracted from 2 publications · Model version —From source
  • Publications34 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-3829-289XORCIDFrom source
  • Last synchronised5 November 2026 08:56https://suleymanyalcinsh.saglik.gov.tr/TR-1493237/doktorlarimiz.html#pinar-tiglioglusaglik.gov.tr

Scientific work

Publications on Lymphoma, Large B-Cell, Diffuse

34 publications
Publications by year Most: 15, in 2021
  1. 2021: 15 publications
  2. 2022: 8 publications
  3. 2023: 1 publication
  4. 2024: 2 publications
  5. 2025: 5 publications
  6. 2026: 3 publications

  1. Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study

    Leukemia Research, 2026

    DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Source: OpenAlex

  2. Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL

    Annals of Hematology, 2026

    DOI 10.1007/s00277-026-07201-y PMID 42897372 Open-access full textSource: ORCID

  3. Publication Only

    HemaSphere, 2026

    DOI 10.1002/hem3.70421 Open-access full textSource: OpenAlex

  4. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14207294 PMID 41156164 Open-access full textSource: OpenAlex

  5. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14196813 PMID 41095893 Open-access full textSource: OpenAlex

  6. Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06644-z PMID 41074982 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Immunological biomarkers and TARC/CCL17 in myelodysplastic syndrome: Insights into immune microenvironment regulation

    Blood, 2025

    DOI 10.1182/blood-2025-7359 Open-access full textSource: OpenAlex

  8. CURRENT TREATMENT METHODS FOR EARLY RELAPSED MULTIPLE MYELOMA

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-694-3_p55 Source: OpenAlex

  9. A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study

    Medicine, 2024

    DOI 10.1097/md.0000000000037802 PMID 38608056 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies

    Cureus, 2024

    DOI 10.7759/cureus.51572 PMID 38314000 1 citation (OpenAlex) Open-access full textSource: OpenAlex

View all 34 publications